Science & Enterprise subscription

Follow us on Twitter

  • A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing thera… https://t.co/HTEdzTQVvO
    about 19 hours ago
  • New post on Science and Enterprise: Industry, Univ Labs Partner on Cannabinoid Pain Drug https://t.co/ZrZF5dm5Ce #Science #Business
    about 19 hours ago
  • https://t.co/037qhZ8zQ2 Go Hawks ... in this case, a sharp-shinned hawk, according to @CornellBirds
    about 22 hours ago
  • An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2… https://t.co/NCatkkRGQq
    about 23 hours ago
  • New post on Science and Enterprise: Simpler Method Devised to Validate Covid-19 Tests https://t.co/PC6JYOVo7T #Science #Business
    about 23 hours ago

Please share Science & Enterprise

Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Inspecting lung X-rays

Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Online App Encourages Abstinence in Alcohol Addiction

Pouring a drink

Results from a clinical trial show users of an online abstinence training app are less likely to relapse in alcohol consumption than sham training app users. . . . → Read More: Online App Encourages Abstinence in Alcohol Addiction

Infographic – Mental Health Effects of Pandemic

Covid-19 and mental health chart

Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention. . . . → Read More: Infographic – Mental Health Effects of Pandemic

Advanced Solid Tumor Precision Meds. Trial Begins

Brain tumor graphic

A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors. . . . → Read More: Advanced Solid Tumor Precision Meds. Trial Begins

Biotech IDs Potent Covid-19 Antibodies

SARS-Cov-2 virus

A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Biotech IDs Potent Covid-19 Antibodies

Drug Maker Licenses Low-Dose Vaccine Patch

Nanopatch system

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

TB Vaccine Test on Covid-19 Expanding to Europe

SARS-Cov-2 virus

A clinical trial testing a current tuberculosis vaccine among health care workers in Australia is expanding in that country and to two European countries. . . . → Read More: TB Vaccine Test on Covid-19 Expanding to Europe

Case Study Maps Covid-19 Immune Response

Coronavirus

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response

Patch Delivers Low-Dose Vaccine with Full-Dose Power

Influenza virus

A clinical trial shows a polymer patch with one-sixth of the usual influenza vaccine dose generates about the same immune reaction as a full-dose injection. . . . → Read More: Patch Delivers Low-Dose Vaccine with Full-Dose Power

Intl Group Calls for More Coronavirus Vaccines

Hong Kong residents in masks

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines